Published: 27th September 2021 - All information correct at time of publication.
The new clinical structure that will help to deliver the future vision for world-class pathology services in South East London is now in place.
SYNLAB is working in partnership with Guy’s and St Thomas’, and King’s College Hospital NHS Foundation Trusts – as well as existing services provider Viapath – to transform pathology services for hospitals, GPs, community services and other NHS healthcare providers.
To ensure that pathology services are truly clinically led, joined up and integrated across all sites, a new structure – based on the partnership’s clinical functions rather than by location – has been implemented.
It has involved replacing the site clinical directors for Guy’s and St Thomas’, King’s College and Princess Royal University hospitals with Strategic Clinical Leads (SCLs) for each of the core groups: Tissue Sciences, Genomics, Haematology, Clinical Chemistry and Immunology, and Infection Sciences.
The SCLs report to new pathology partnership Medical Director Dr Paul Cane, who has close to two decades’ experience as a South East London-based consultant in his specialist area of histopathology.
The new model demonstrates the pathology partnership’s commitment to putting clinicians at the forefront of service delivery and improvement, so that every decision is made with the best interests of patients and those who provide their care at its heart
The New Clinical Structure is:
- Dr Royce Vincent: Chemistry and Immunology, based at King’s College Hospital
- Dr Silke Schelenz: Infection Sciences, based at King’s College Hospital
- Prof Beverley Hunt: Haematology, based at Guy’s and St Thomas’ hospitals
- Dr Giuseppe Culora and Dr Mark Howard: Tissue Sciences – joint appointment – Dr Culora based at Guy’s and St Thomas’ hospitals; Dr Howard based at King’s College Hospital
- Dr Deborah Ruddy: Genomics, based at Guy’s and St Thomas’ hospitals
We have assembled a very strong team of Strategic Clinical Leads, all of whom are experts in their fields and highly regarded by their peers.
Dr Paul Cane, Medical Director
They are working hard preparing their services for transformation, including arriving at a single test directory for GSTT and KCH and designing our centralised hub laboratory and hospital labs. They will be playing a leading role in the clinical governance of our services and acting as the interface between laboratories and our clinical colleagues.
I hope you will join me in welcoming them to these important positions and wishing them every success.
